Targeting the Adenosine‐Mediated Metabolic Immune Checkpoint with Engineered Probiotic for Enhanced Chemo‐Immunotherapy
Abstract Immunotherapy has revolutionized cancer treatment by leveraging the patient's immune system, yet its efficacy is often hampered by the immunosuppressive tumor microenvironment (TME). Adenosine, a key player in this milieu, suppresses immune cell activity via cAMP signaling. Here, an in...
Saved in:
| Main Authors: | Jinhui Wang, Jing Wang, Zhijie Yu, Hongyu Wen, Chensi Zhao, Jiayong Zhong, Chuanle Xiao, Yingqiu Li, Jianqiao Xu, Jinquan Wang, Zong‐Wan Mao, Wei Xia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Advanced Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/advs.202411813 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigation of Adenosine deamidase (ADA) activity and some biochemical values in lambs with infectious ecthyma symptoms
by: S. Kızıltepe, et al.
Published: (2025-07-01) -
Estimation of Nitric Oxide, Malondialdehyde, and Adenosine Deaminase in Serum of Hypertensive Patients and Normotensive Individuals in Erbil City
by: Gulzar I. Ibrahim, et al.
Published: (2019-05-01) -
Adenosine Deaminase and Systemic Immune Inflammatory Index—A Biomarker Duet Signature of Pulmonary Tuberculosis Severity
by: Ioan Anton Arghir, et al.
Published: (2025-06-01) -
The possibility of predicting effectiveness oftherapy in patients with new infiltrative pulmonary tuberculosis by baseline activity of adenosine deaminase and inflammatory response parameters
by: M. E. Dyakova, et al.
Published: (2022-06-01) -
Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open‐label, single‐arm, phase 3, and postmarketing clinical study
by: Masafumi Onodera, et al.
Published: (2023-07-01)